ICON Clinical Research LLC is part of ICON plc, so its service offering aligns with ICON’s global CRO portfolio across the full drug and device development lifecycle.

Core clinical trial services

ICON Clinical Research LLC supports planning, setup, and execution of Phase I–IV clinical trials, including protocol design, site selection, project management, monitoring, and trial operations. It also provides data management, biostatistics, medical writing, safety/pharmacovigilance, and quality/compliance services to generate, clean, and analyze study data for regulatory submissions.

Specialized and early-phase services

ICON offers early clinical and bioanalytical solutions such as first‑in‑human studies, clinical pharmacology, early phase oncology, and bioanalytical/laboratory testing through integrated clinical research facilities and labs. The organization also runs specialty and central laboratories providing bioanalytical assays, biomarkers, vaccine testing, and other precision medicine‑focused services.

Patient, site, and real‑world solutions

ICON provides site and patient solutions focused on recruitment, retention, decentralized and hybrid trials, home health visits, and use of wearables and mobile health technologies. It also offers real‑world intelligence, health data analytics, and outcomes/market access research to support evidence generation after approval and inform pricing, reimbursement, and access strategies.

Consulting, biotech, and commercialization support

The company delivers consulting and advisory services including regulatory affairs, quantitative pharmacology, health economics and outcomes research, market research and analytics, and due diligence/asset valuation. Dedicated biotech‑focused solutions provide flexible full‑service or functional outsourcing for small and mid‑size biopharma, spanning from early development through global programs and commercialization support.